RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET
NCT: NCT07769684 · NOT_YET_RECRUITING
Brief Summary
The goal of this clinical trial is to examine the effect of ETN on live birth rate in patients with diminished ovarian reserve (DOR) undergoing in vitro fertilizitaion-embryo transfer (IVF-ET). Four hundred and six patients with DOR will be enrolled randomly divided into treatment group and control group, with 203 patients in each group. The treatment group will receive electro-thumbtack needle (ETN) therapy, while the control group received placebo ETN. Both groups initiated treatment 1 to 3 menstrual cycles before IVF-ET and continued until the intramuscular injection of HCG (night injection) during the IVF cycle. The study will observe and compare the pregnancy outcomes (including live birth rate, clinical pregnancy rate, biochemical pregnancy rate, threatened abortion, abortion, oocyte retrieval, and embryo quality), ovarian reserve function, anxiety, depression, sleep status, and quality of life between the two groups.
Frequently Asked Questions
What is RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET?
RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET is a clinical trial registered under NCT07769684. Current status: NOT_YET_RECRUITING.
What is the status of NCT07769684?
The current status of NCT07769684 (RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET) is: NOT_YET_RECRUITING.
When did RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET start?
RCT Study on the Effect of ETN on Live Birth Rate in DOR Patients Undergoing IVF-ET started on 2026-08-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.